This inventor holds 2 USPTO granted patents. Top assignees: Northwestern University, University of Illinois. Active years: 2017-2018.
Company Filing History:
2 out of 2,213 
2 out of 2,421 
Years Active: 2017-2018
Title: Innovations by Nichole E LaPointe
Introduction
Nichole E LaPointe is a prominent inventor based in Santa Barbara, CA (US). She has made significant contributions to the field of tauopathy research, with a focus on developing compositions and methods for prevention and treatment. Her innovative work has led to the filing of 2 patents that address critical issues related to tauopathies.
Latest Patents
LaPointe's latest patents include a composition and method for preventing or treating a tauopathy. This invention involves the use of N-terminal amino acid residues of the tau protein, which play a crucial role in the toxic activation of a PP1/GSK3 signaling cascade and the inhibition of fast axonal transport in human tauopathies. Another patent focuses on a similar composition and method for treating tauopathies, emphasizing the importance of these amino acid residues in addressing the underlying mechanisms of the disease.
Career Highlights
Throughout her career, Nichole E LaPointe has worked with esteemed institutions such as Northwestern University and the University of Illinois. Her research has garnered attention for its potential impact on understanding and treating tauopathies, which are associated with neurodegenerative diseases.
Collaborations
LaPointe has collaborated with notable colleagues, including Scott Thomas Brady and Nicholas Kanaan. These partnerships have contributed to her research and the advancement of knowledge in the field of tauopathy.
Conclusion
Nichole E LaPointe's innovative work in the realm of tauopathy research showcases her dedication to advancing medical science. Her patents reflect her commitment to finding effective treatments for complex neurological conditions.